Hematopoietic SCT for adult T-cell leukemia/lymphoma: A review

Bone Marrow Transplantation

Volumn 46, Issue 8, 2011, Pages 1039-1044

  Jabbour, M ^a,b   Tuncer, H ^a,b   Castillo, J ^c   Butera, J ^c   Roy, T ^a   Pojani, J ^a   Al Malki, M ^d   Al Homsi, A S ^a,b  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d Our Lady of Fatima Hospital   (United States)

Author keywords

adult T cell leukemia; SCT; T cell lymphoma

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; ARSENIC TRIOXIDE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACLIZUMAB; DENILEUKIN DIFTITOX; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; VINDESINE; ZIDOVUDINE;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG RESPONSE; DRUG WITHDRAWAL; GRAFT DYSFUNCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION; INTERSTITIAL PNEUMONIA; JAPAN; MYELOABLATIVE CONDITIONING; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SEPSIS; SURGICAL MORTALITY; T CELL LEUKEMIA; THROMBOCYTOPENIA; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VIRUS CARCINOGENESIS;

ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED;

EID: 80051680491     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.27     Document Type: Review

References (38)

1. Shuh M, Beilke M. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM). Microsc Res Tech 2005; 68: 176-196. (Pubitemid 41696968)
2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005; 24: 6058-6068. (Pubitemid 43086123)
3. Matsuoka M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2005; 2: 27.
4. Kenji I, Kazuo T. Treatment of adult T-cell leukemia/lymphoma: past, present, and future. Eur J Haematol 2008; 80: 185-196.
5. Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M, Morris D. Successful treatment of HTLV-1 associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol 1996; 94: 713-715. (Pubitemid 26308908)
6. Ohshima K, Jaffe ES, Kikuchi M. Adult T-cell leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008, 281-284.
7. Di Venuti G, Nawgiri R, Foss F. Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia/lymphoma. Clin Lymphoma 2003; 4: 176-178. (Pubitemid 38128682)
8. Ratner L. Pathogenesis and treatment of human T-cell leukemia virus infection. Immunol Res 2005; 32: 217-223. (Pubitemid 41153627)
9. Johnson JM, Harrod R, Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int J Exp Pathol. 2001; 82: 135-147. (Pubitemid 32718496)
10. Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, Murphy E, Sabino E, Hisada M et al. HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica 2006; 19: 44-53. (Pubitemid 44131314)
11. + cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 2001; 17: 1047-1061. (Pubitemid 32881324)
12. Yasunaga J, Matsuoka M. Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms. Cancer Control 2007; 14: 133-140. (Pubitemid 46515149)
13. Ratner L. Adult T cell leukemia lymphoma. Front Biosci. 2004; 1: 2852-2859.
14. van Zaanen HC, Pegels JG. Adult T-cell leukaemia and lymphoma: report of two cases and a brief review of the literature. Neth J Med 2002; 60: 330-333. (Pubitemid 39089341)
15. Ohshima K. Pathological features of diseases associated with human T-cell leukemia virus type I. Cancer Sci 2007; 98: 772-778. (Pubitemid 46691812)
16. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukush-ima T, Takatsuka Y et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007; 25: 5458-5464. (Pubitemid 350232223)
17. Hermine O, Allard I, Levy V, Arnulf B, Gessain A, Bazarbachi A et al. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. Hematol J 2002; 3: 276-282. (Pubitemid 36163756)
18. Mone A, Puhalla S, Whitman S, Baiocchi R, Cruz J, Vukosavljevic T et al. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia. Blood 2005; 106: 3380-3382. (Pubitemid 41609170)
19. Hermine O, Dombret H, Poupon J, Arnulf B, Lefrere F, Rousselot P et al. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma. Hematol J 2004; 5: 130-134. (Pubitemid 38519262)
20. Evens AM, Ziegler SL, Gupta R, Augustyniak C, Gordon LI, Mehta J et al. Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma. Clin Lymphoma Myeloma 2007; 7: 472-474. (Pubitemid 47436648)
21. Ravandi F, Faderl S. Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin. Leuk Res 2006; 30: 103-105. (Pubitemid 41654712)
22. Tsukasaki K, Maeda T, Arimura K, Taguchi J, Fukushima T, Miyazaki Y et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999; 23: 87-89. (Pubitemid 29050184)
23. Sobue R, Yamauchim T, Miyamura K, Sao H, Tahara T, Yoshikawa S et al. Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation. Bone Marrow Transplant 1987; 2: 441-444. (Pubitemid 18028293)
24. Tamaki H, Matsuoka M. Donor-derived T-cell leukemia after bone marrow transplantation. N Engl J Med 2006; 355: 1758-1759.
25. Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005; 19: 829-834. (Pubitemid 40663104)
26. Matsushishi K, Arima N, Ohtsubo H, Fujiwara H, Hidaka S, Kukita T et al. Granulocyte-colony stimulating factor-induced proliferation of primary adult T-cell leukemia cells. Br J Haematol. 1997; 96: 715-723. (Pubitemid 27115864)
27. Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15-20. (Pubitemid 32124402)
28. Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 2005; 105: 4143-4145. (Pubitemid 40656167)
29. Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, Tomonaga M et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant 2008; 14: 702-708. (Pubitemid 351681417)
30. Yonekura K, Utsunomiya A, Takatsuka Y, Takeuchi S, Tashiro Y, Kanzaki T et al. Graft-versus-adult T cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 1029-1035. (Pubitemid 352034178)
31. Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the japan marrow donor program. Biol Blood Marrow Transplant 2007; 13: 90-99. (Pubitemid 46044093)
32. Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamo-to S, Nishio M et al. Retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Biol Blood Marrow Transplant 2008; 14: 817-823. (Pubitemid 351773158)
33. Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukemia/lymphoma. Br J Haematol 2003; 120: 304-309. (Pubitemid 36194182)
34. Miyamura F, Kako S, Yamagami H, Sato K, Terasako K, Kimura S et al. Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2009; 90: 397-401.
35. Nakase K, Hara M, Kozuka T, Tanimoto K, Nawa Y. Bone marrow transplantation from unrelated donor for patients with adult T-cell leukemia/lymphoma. Bone Marrow Transplant 2006; 37: 41-44. (Pubitemid 43135313)
36. Obama K, Tara M, Sao H, Taji H, Morishima Y, Mougi H et al. Allogeneic bone marrow transplantation as a treatment for adult T-cell Leukemia. Int J Hematol 1999; 69: 203-205.
37. Ogata M, Ogata Y, Imamura T, Ohtsuka E, Kikuchi H, Utsunomiya A et al. Successful bone marrow transplant from an unrelated donor in patient with adult T cell leukemia. Bone Marrow Transplant 2002; 30: 699-701. (Pubitemid 35446652)
38. Tajima K, Amakawa R, Uehira K, Matsumoto N, Shimizu T, Miyazaki Y et al. Adult T-cell leukemia successfully treated with allogeneic bone marrow transplantation. Int J Hematol 2000; 71: 290-293.